RSV Vaccine VIS | Vaccines & Immunizations | CDC
Summary: This Vaccine Information Statement (VIS) explains the importance of the RSV vaccine, who should receive it, potential side effects, and how to report adverse reactions.
The CDC's Vaccine Information Statement (VIS) for the Respiratory Syncytial Virus (RSV) vaccine outlines the risks of RSV, which can cause severe respiratory illness in infants and older adults. The document details vaccination recommendations: a one-time dose for pregnant women (weeks 32–36) to protect infants, and a one-time dose for adults 75 and older, as well as adults 60–74 at increased risk. It covers safety information, including common side effects like pain at the injection site, fatigue, and fever, as well as rare concerns like Guillain-Barré syndrome. The document also provides guidance on when to seek medical attention for allergic reactions and how to report adverse events via VAERS or V-Safe.
Document outline
1. 1. Why get vaccinated? 2. 2. RSV vaccine 3. 3. Talk with your health care provider 4. 4. Risks of a vaccine reaction 5. 5. What if there is a serious problem? 6. 6. How can I learn more?